摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-(2-甲基苯氧基)吡咯烷 | 46196-54-7

中文名称
3-(2-甲基苯氧基)吡咯烷
中文别名
3-(邻-甲苯氧基)吡咯烷
英文名称
3-(2-Methylphenoxy)pyrrolidine
英文别名
——
3-(2-甲基苯氧基)吡咯烷化学式
CAS
46196-54-7
化学式
C11H15NO
mdl
——
分子量
177.24
InChiKey
MIVMFYNEGPHLSB-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2
  • 重原子数:
    13
  • 可旋转键数:
    2
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.45
  • 拓扑面积:
    21.3
  • 氢给体数:
    1
  • 氢受体数:
    2

安全信息

  • 海关编码:
    2933990090

SDS

SDS:260f32cd07618de9e1751b9ac8f844d4
查看

文献信息

  • Tetraaza-cyclopenta[a]indenyl and their use as positive allosteric modulators
    申请人:Ares Trading S.A.
    公开号:EP2607364A1
    公开(公告)日:2013-06-26
    The present invention provides compounds of Formula (I) as M1 receptor positive allosteric modulators for the treatment of diseases mediated by the muscarinic M1 mediator.
    本发明提供了Formula (I)的化合物作为M1受体阳性变构调节剂,用于治疗由M1胆碱能介质介导的疾病。
  • QUINOLINE-CARBOXAMIDE DERIVATIVES AS P2Y12 ANTAGONISTS
    申请人:Nazaré Marc
    公开号:US20100135999A1
    公开(公告)日:2010-06-03
    The present invention relates to compounds of the formula I, in which R 1 ; R 2 ; R 3 ; R 4 ; R 5 ; R 6 ; Z; A; B; E; X; Q; J; V; G and M have the meanings indicated in the claims. The compounds of the formula I are valuable pharmacologically active compounds. They exhibit a strong anti-aggregating effect on platelets and thus an anti-thrombotic effect and are suitable e.g. for the therapy and prophylaxis of cardio-vascular disorders like thromboembolic diseases or restenoses. They are reversible antagonists of the platelet ADP receptor P2Y12, and can in general be applied in conditions in which an undesired activation of the platelet ADP receptor P2Y12 is present or for the cure or prevention of which an inhibition of the platelet ADP receptor P2Y12 is intended. The invention furthermore relates to processes for the preparation of compounds of the formula I, their use, in particular as active ingredients in pharmaceuticals, and pharmaceutical preparations comprising them.
    本发明涉及公式I的化合物,其中R1; R2; R3; R4; R5; R6; Z; A; B; E; X; Q; J; V; G和M具有所述声明中指示的含义。公式I的化合物是有价值的药理活性化合物。它们对血小板具有强烈的抗聚集作用,从而具有抗血栓作用,适用于治疗和预防心血管疾病,如血栓栓塞病或再狭窄。它们是血小板ADP受体P2Y12的可逆拮抗剂,通常适用于存在不良激活血小板ADP受体P2Y12的情况,或者治愈或预防需要抑制血小板ADP受体P2Y12的情况。此外,本发明还涉及制备公式I化合物的方法,它们的用途,特别是作为药物中的活性成分,以及包含它们的制药制剂。
  • Inhibitors of Ion Channels
    申请人:Marron Brian Edward
    公开号:US20130072471A1
    公开(公告)日:2013-03-21
    Compounds, compositions and methods are provided which are useful in the treatment of diseases through the inhibition of sodium ion flux through voltage-gated sodium channels. More particularly, the invention provides substituted aryl sulfonamides, compositions comprising these compounds, as well as methods of using these compounds or compositions in the treatment of central or peripheral nervous system disorders, particularly pain and chronic pain by blocking sodium channels associated with the onset or recurrence of the indicated conditions. The compounds, compositions and methods of the present invention are of particular use for treating neuropathic or inflammatory pain by the inhibition of ion flux through a voltage-gated sodium channel.
    本发明提供了在通过抑制电压门控钠通道中的钠离子流来治疗疾病方面有用的化合物、组合物和方法。更具体地,本发明提供了取代芳基磺酰胺、包含这些化合物的组合物,以及使用这些化合物或组合物治疗中枢或外周神经系统疾病,特别是疼痛和慢性疼痛的方法,通过阻断与所示条件的发生或复发相关的钠通道来实现。本发明的化合物、组合物和方法特别适用于通过抑制电压门控钠通道中的离子流来治疗神经病性或炎症性疼痛。
  • INHIBITORS OF ION CHANNELS
    申请人:Marron Brian Edward
    公开号:US20090143358A1
    公开(公告)日:2009-06-04
    Compounds, compositions and methods are provided which are useful in the treatment of diseases through the inhibition of sodium ion flux through voltage-gated sodium channels. More particularly, the invention provides substituted aryl sulfonamides, compositions comprising these compounds, as well as methods of using these compounds or compositions in the treatment of central or peripheral nervous system disorders, particularly pain and chronic pain by blocking sodium channels associated with the onset or recurrence of the indicated conditions. The compounds, compositions and methods of the present invention are of particular use for treating neuropathic or inflammatory pain by the inhibition of ion flux through a voltage-gated sodium channel.
    本发明提供了化合物、组合物和方法,通过抑制电压门控钠通道中的钠离子流来治疗疾病。更具体地,本发明提供了取代芳基磺酰胺、包含这些化合物的组合物,以及使用这些化合物或组合物治疗中枢或外周神经系统疾病,特别是疼痛和慢性疼痛的方法,通过阻止与所示疾病的发生或复发有关的钠通道。本发明的化合物、组合物和方法特别适用于通过抑制电压门控钠通道中的离子流来治疗神经病理性或炎症性疼痛。
  • NITROGEN CONTAINING COMPOUNDS AND THEIR USE AS ANTIBACTERIAL AGENTS
    申请人:WOCKHARDT LIMITED
    公开号:US20160355516A1
    公开(公告)日:2016-12-08
    Compounds of Formula (I), their preparation, and use in preventing or treating a bacterial infection are disclosed. (I)
查看更多